Loading...

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

BACKGROUND: Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. CASE PRESENTATION: We report a female patient with disseminated melanoma metastases. Two days after the first dosage of combined immunotherapy using the cytotoxic T lymphocyte antigen-4 (CT...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Gambichler, Thilo, Stockfleth, E., Susok, L.
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208032/
https://ncbi.nlm.nih.gov/pubmed/30376886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0430-y
Tags: Add Tag
No Tags, Be the first to tag this record!